Latanoprost/timolol

Drug Profile

Latanoprost/timolol

Alternative Names: Timolol/latanoprost; Xalacom; Xalatan/timolol; Xalcom

Latest Information Update: 09 Feb 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Class Amino alcohols; Antiglaucomas; Antihypertensives; Eye disorder therapies; Morpholines; Propanolamines; Prostaglandins; Small molecules; Thiadiazoles
  • Mechanism of Action Beta-adrenergic receptor antagonists; Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Glaucoma; Ocular hypertension

Most Recent Events

  • 08 Feb 2012 Generic equivalent available in United Kingdom
  • 25 Jan 2012 Generic equivalent available in Denmark, Finland & Ireland
  • 28 Jun 2003 Launched for Glaucoma in Canada (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top